ACCURACY a phase II trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notchmut) Meeting Abstract
| Authors: | Ferrarotto, R.; Wirth, L. J.; Muzaffar, J.; Rodriguez, C. P.; Xia, B.; Perez, C. A.; Bowles, D. W.; Winquist, E.; Hotte, S. J.; Metcalf, R.; Even, C.; Gordon, G. B.; Gordon, G.; Ho, A. |
| Abstract Title: | ACCURACY a phase II trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notchmut) |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S663 |
| Language: | English |
| ACCESSION: | WOS:000573469101207 |
| DOI: | 10.1016/j.annonc.2020.08.1034 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 919MO -- Source: Wos |
